(TPVG) Triplepoint Venture Growth - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US89677Y1001
TPVG: Debt Financing, Growth Capital Loans, Equity Investments, Venture Capital
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company. Web URL: https://www.tpvg.com
Additional Sources for TPVG Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TPVG Stock Overview
Market Cap in USD | 300m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 2014-03-06 |
TPVG Stock Ratings
Growth 5y | -6.94% |
Fundamental | -18.4% |
Dividend | 75.5% |
Rel. Strength Industry | -161 |
Analysts | 3/5 |
Fair Price Momentum | 7.71 USD |
Fair Price DCF | 27.70 USD |
TPVG Dividends
Dividend Yield 12m | 18.40% |
Yield on Cost 5y | 19.36% |
Annual Growth 5y | -1.89% |
Payout Consistency | 96.7% |
TPVG Growth Ratios
Growth Correlation 3m | 38.8% |
Growth Correlation 12m | -75.4% |
Growth Correlation 5y | 7.8% |
CAGR 5y | 1.04% |
CAGR/Mean DD 5y | 0.05 |
Sharpe Ratio 12m | -0.60 |
Alpha | -58.68 |
Beta | 1.73 |
Volatility | 24.37% |
Current Volume | 392.8k |
Average Volume 20d | 519.4k |
What is the price of TPVG stocks?
As of January 22, 2025, the stock is trading at USD 7.61 with a total of 392,752 shares traded.
Over the past week, the price has changed by +1.33%, over one month by +5.40%, over three months by +17.11% and over the past year by -20.80%.
As of January 22, 2025, the stock is trading at USD 7.61 with a total of 392,752 shares traded.
Over the past week, the price has changed by +1.33%, over one month by +5.40%, over three months by +17.11% and over the past year by -20.80%.
Is Triplepoint Venture Growth a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Triplepoint Venture Growth is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -18.41 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TPVG as of January 2025 is 7.71. This means that TPVG is currently overvalued and has a potential downside of 1.31%.
Neither. Based on ValueRay Fundamental Analyses, Triplepoint Venture Growth is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -18.41 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TPVG as of January 2025 is 7.71. This means that TPVG is currently overvalued and has a potential downside of 1.31%.
Is TPVG a buy, sell or hold?
Triplepoint Venture Growth has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold TPVG.
Triplepoint Venture Growth has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold TPVG.
- Strong Buy: 0
- Buy: 0
- Hold: 8
- Sell: 0
- Strong Sell: 0
What are the forecast for TPVG stock price target?
According to ValueRays Forecast Model, TPVG Triplepoint Venture Growth will be worth about 8.8 in January 2026. The stock is currently trading at 7.61. This means that the stock has a potential upside of +15.37%.
According to ValueRays Forecast Model, TPVG Triplepoint Venture Growth will be worth about 8.8 in January 2026. The stock is currently trading at 7.61. This means that the stock has a potential upside of +15.37%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 7.9 | 4.1% |
Analysts Target Price | 11.1 | 45.7% |
ValueRay Target Price | 8.8 | 15.4% |